About ARS Pharmaceuticals, Inc. 
ARS Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 51 Schemes (21.72%)
Foreign Institutions
Held by 82 Foreign Institutions (10.59%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
23 Million
(Quarterly Results - Mar 2026)
Net Profit:
-61 Million
Pharmaceuticals & Biotechnology
USD 801 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.30
-150.01%
7.01






